Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Chemmedchem
|
August 2, 2008
Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors
Sofia Pettersson, Violeta I Pérez-Nueno, Laia Ros-Blanco, et al.
Journal of Medicinal Chemistry
|
June 13, 2018
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2012
Imidazo[1,2-a]pyrazines as novel PI3K inhibitors
Sonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Journal of Medicinal Chemistry
|
March 4, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Journal of Medicinal Chemistry
|
September 9, 2016
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
Haematologica
|
December 2, 2017
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms
Jon Celay, Teresa Lozano, Axel R Concepcion, et al.
ACS Chemical Neuroscience
|
December 12, 2018
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
European Journal of Medicinal Chemistry
|
March 18, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
The Journal of Biological Chemistry
|
August 20, 2009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases
Wolfgang Link, Julen Oyarzabal, Beatriz G Serelde, et al.
ACS Chemical Neuroscience
|
August 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Chemmedchem
|
August 2, 2008
Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors
Sofia Pettersson, Violeta I Pérez-Nueno, Laia Ros-Blanco, et al.
Journal of Medicinal Chemistry
|
June 13, 2018
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2012
Imidazo[1,2-a]pyrazines as novel PI3K inhibitors
Sonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Journal of Medicinal Chemistry
|
March 4, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Journal of Medicinal Chemistry
|
September 9, 2016
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
Haematologica
|
December 2, 2017
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms
Jon Celay, Teresa Lozano, Axel R Concepcion, et al.
ACS Chemical Neuroscience
|
December 12, 2018
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
European Journal of Medicinal Chemistry
|
March 18, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
The Journal of Biological Chemistry
|
August 20, 2009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases
Wolfgang Link, Julen Oyarzabal, Beatriz G Serelde, et al.
ACS Chemical Neuroscience
|
August 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
Page
of 6